CARDIO-ONCOLOGY IN REAL PRACTICE: FACTS AND CHALLENGES IN THE TREATMENTOF METASTATIC LUNG CANCER

Abstract

Innovations in oncology practically gave new possibilities for treatment of patients with cancer.
This also applies to lung cancer, which is still considered to be a leading cause of cancer-related death
and has long been a challenge for both researchers and clinicians. The last decade is defined as a time of
scientific and clinical progress that practically changed the treatment approach in lung cancer and rewrote
therapeutic paradigms by introducing innovative treatment approaches, including targeted therapies and
immunotherapies. Cardio-oncology is a new direction in medicine focused on monitoring and treatment
of cancer patients. It reflects the importance of cooperation between cardiologists and oncologists in the
joint treatment of patients with cancer, and the leading principle is personalized approach in the treatment
of patient. The main role of the cardiologist is early detection of subclinical cardiotoxicity, timely prevention
and treatment, which requires strict follow-up according to the baseline risk of developing cardiotoxicity.
The aim is achieving better outcome, better quality of life and better survival. This article aims to briefly
describe some of the main and most important advances of immunotherapy in the treatment of lung
cancer and to practically visualize the key role of cardio-oncology teamwork.